Results 221 to 230 of about 30,754 (261)

Inflammation in HFpEF: Key or circumstantial?

open access: yesInternational Journal of Cardiology, 2015
Heart failure (HF) can be split into HF with reduced ejection fraction (HFrEF) and HF with preserved ejection fraction (HFpEF). Currently the pathophysiologic mechanisms involved in HFpEF remain largely unknown.
Hans-Peter Brunner-La Rocca   +1 more
exaly   +2 more sources

Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle

open access: yesCardiovascular Research, 2018
Half of all heart failure patients have preserved ejection fraction (HFpEF). Comorbidities associated with and contributing to HFpEF include obesity, diabetes and hypertension. Still, the underlying pathophysiological mechanisms of HFpEF are unknown.
Blanche Louise Maria Schroen   +2 more
exaly   +2 more sources

Myocardial Metabolic Reprogramming in HFpEF

Journal of Cardiovascular Translational Research, 2023
Heart failure (HF) caused by structural or functional cardiac abnormalities is a significant cause of morbidity and mortality worldwide. While HF with reduced ejection fraction (HErEF) is well understood, more than half of patients have HF with preserved ejection fraction (HFpEF).
Zihui Zhang   +5 more
openaire   +2 more sources

Lifestyle interventions in cardiometabolic HFpEF: dietary and exercise modalities [PDF]

open access: yesHeart Failure Reviews
Heart failure with preserved ejection fraction (HFpEF) is rapidly growing as the most common form of heart failure. Among HFpEF phenotypes, the cardiometabolic/obese HFpEF - HFpEF driven by cardiometabolic alterations - emerges as one of the most ...
Federico Capone   +2 more
exaly   +2 more sources

Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF

JACC: Heart Failure
Because of the bidirectional relationship between atrial fibrillation (AF) and heart failure with preserved ejection fraction (HFpEF), individuals with either condition require consideration of screening for the other. In this review, we summarize current evidence and rationale for screening for occult HFpEF in adults with clinical AF; and occult AF in
Yogesh N V, Reddy   +3 more
openaire   +2 more sources

Istaroxime in HFpEF

JACC: Heart Failure, 2023
Ryan J. Tedford, Daniel N. Silverman
openaire   +1 more source

HFpEF Explained — Living with HFpEF

New England Journal of Medicine
Sadiya S. Khan   +7 more
openaire   +1 more source

A Biomarker Approach to Understanding HFpEF

Journal of the American College of Cardiology, 2020
Dalane W, Kitzman   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy